Summary
- Current Price
- As of today, BLSM price is $17.29, down -13.29% on
- Current Price All-Time High
- BLSM price is currently -38.23% below its historical high of $27.99 set on
- Market Cap
- BLSM current market cap is $550M
- Revenue
- BLSM current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for BLSM is on
Profile
| Metric | Value |
|---|---|
| Full Name | BlossomHill Therapeutics, Inc. |
| Ticker | NASDAQ: BLSM |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | bhtherapeutics.com |
| Employees | 63 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $17.29 | |
| Price, 1D Change | -13.29% | |
| $550M | ||
| - | ||
| - | ||
| 0.85 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.91 | ||
| EPS, 1Y Change | -97.29% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | N/A | |
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.91 | ||
| EPS Estimate | - | |
| EPS Est. Change | - | |
| $0.00 | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $17.29 | |
| Price Target | $35.00 | - |
| Price Tgt. Change | +102.43% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$0.97 | - | |
| - | -$1.91 | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $17.29 | |
| $19.78 | ||
| $19.78 | ||
| - | ||
| - | ||
| -$0.06 | ||
| 0.85 | ||
| $1.93 | ||
| 39.19 | ||
| 122.78% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$1.91 | ||
| -$441.00K | ||
| - | ||
| -$64.02M | ||
| - | ||
| -$60.56M | ||
| - | ||
| -$63.58M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| -2.12 | ||
| 8.97 | ||
| 8.97 | ||
| - | ||
| - | ||
| -0.41 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| -3.14 | ||
| -15.78 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$131.73M | ||
| $136.68M | ||
| $167.30M | ||
| $138.83M | ||
| $299.03M | ||
| $15.48M | ||
| $279.22M | ||
| $5,000.00 | ||
| $2.31M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $60.56M | ||
| $63.58M | ||
| $441.00K | ||
| $7.89M | ||
| $441.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$46.93M | ||
| -$1.07M | ||
| $84.53M | ||
| $1.07M | ||
| -$47.99M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Leerink Partners | → | |
| Guggenheim | → | |
| LifeSci Capital | ||
| Leerink Partners | ||
| JP Morgan | ||
| HC Wainwright & Co. | ||
| Guggenheim |
Analyst sentiment
Institutional ownership
No data
Screeners with BLSM
FAQ
- What is the ticker symbol for BlossomHill Therapeutics, Inc.?
- The ticker symbol for BlossomHill Therapeutics, Inc. is NASDAQ:BLSM
- Does BlossomHill Therapeutics, Inc. pay dividends?
- No, BlossomHill Therapeutics, Inc. does not pay dividends
- What sector is BlossomHill Therapeutics, Inc. in?
- BlossomHill Therapeutics, Inc. is in the Healthcare sector
- What industry is BlossomHill Therapeutics, Inc. in?
- BlossomHill Therapeutics, Inc. is in the Biotechnology industry
- What country is BlossomHill Therapeutics, Inc. based in?
- BlossomHill Therapeutics, Inc. is headquartered in United States
- When did BlossomHill Therapeutics, Inc. go public?
- BlossomHill Therapeutics, Inc. initial public offering (IPO) was on August 7, 2026
- Is BlossomHill Therapeutics, Inc. in the S&P 500?
- No, BlossomHill Therapeutics, Inc. is not included in the S&P 500 index
- Is BlossomHill Therapeutics, Inc. in the NASDAQ 100?
- No, BlossomHill Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is BlossomHill Therapeutics, Inc. in the Dow Jones?
- No, BlossomHill Therapeutics, Inc. is not included in the Dow Jones index
- When does BlossomHill Therapeutics, Inc. report earnings?
- The next expected earnings date for BlossomHill Therapeutics, Inc. is November 16, 2026
Data Sources & References
- BLSM Official Website bhtherapeutics.com
- BLSM Profile on Yahoo Finance finance.yahoo.com/quote/BLSM
- BLSM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/blsm